Synopsis (short abstract)Antimicrobial resistance (AMR) is the ability of microorganisms to survive or proliferate in the presence of antimicrobial drugs, posing a significant threat to human and animal health. It increases healthcare and food production costs, and the misuse of antimicrobials exacerbates the problem. Effective stewardship and balancing the trade-offs between financial investments and societal benefits are crucial challenges in addressing AMR.
Bacterial resistance to antimicrobials is increasing, with foodborne transmission contributing significantly. Contaminated food accounts for nearly 20% of infections caused by resistant Escherichia coli. The economic burden of foodborne antimicrobial resistance includes productivity losses and premature deaths, estimated at USD 50 billion in 2019. The World Bank projects a decline in global GDP, livestock production, and exports due to AMR by 2050, with potential negative impacts on international trade.
In conclusion, AMR represents a genuine societal cost, affecting humans, animals, and plants. Therefore, policies are needed to minimize AMR, strengthen food control systems, support responsible antimicrobial use, and promote data sharing.
Last updated date 07/09/2023
Cite this content as:
Topazio, D., Moledina, A. and LeJeune. J. 2023. Foodborne antimicrobial resistance (AMR): an economic concern. Rome, FAO.
